You may have read about eloralintide , an investigational medication Eli Lilly is developing that targets the amylin pathway instead of GLP-1 and showed strong weight loss in a Phase 2 trial reported in The Lancet
If you are working with a 10 mg vial, or planning to, this is the reference you will return to repeatedly
The effects of semaglutide on inflammation and immune activation in HIV-associated lipohypertrophy
Sexual function changes during treatment are more likely related to weight loss itself, which can affect hormones, cardiovascular health, and psychological well-being
Clinical trials for Wegovy, a weight loss drug with the same active ingredient, semaglutide, found that insomnia rates were roughly the same in semaglutide groups versus placebo groups